Cargando…

MRI feature tracking strain is prognostic for all-cause mortality in AL amyloidosis

OBJECTIVES: Cardiac involvement is a major determinate of mortality in light chain (AL) amyloidosis. Cardiac magnetic resonance imaging (MRI) feature tracking (FT) strain is a new method for measuring myocardial strain. This study retrospectively evaluated the association of MRI FT strain with all-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Illman, Jeffery E., Arunachalam, Shivaram P., Arani, Arvin, Chang, Ian Cheng-Yi, Glockner, James F., Dispenzieri, Angela, Grogan, Martha, Araoz, Philip A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405287/ https://www.ncbi.nlm.nih.gov/pubmed/29733684 http://dx.doi.org/10.1080/13506129.2018.1465406

Ejemplares similares

Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis
por: Arani, Arvin, et al.
Publicado: (2017)

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
por: Grogan, Martha, et al.
Publicado: (2017)

Cardiac MR elastography using reduced‐FOV, single‐shot, spin‐echo EPI
por: Sui, Yi, et al.
Publicado: (2017)

Quantitative 3D magnetic resonance elastography: Comparison with dynamic mechanical analysis
por: Arunachalam, Shivaram P., et al.
Publicado: (2016)

Evaluation of myocardial strain in patients with myocardial amyloidosis using feature-tracking technique
por: Pandey, Tarun, et al.
Publicado: (2016)

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Campbell, Courtney M., et al.
Publicado: (2022)

Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial
por: Minnema, Monique C., et al.
Publicado: (2022)

Non‐cardiac biopsy sites with high frequency of transthyretin amyloidosis
por: Dasari, Surendra, et al.
Publicado: (2020)

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
por: Merlini, G, et al.
Publicado: (2016)

Determination of strain pattern in patients with cardiac amyloidosis secondary to Multiple myeloma: a feature tracking study
por: Bhatti, Sabha, et al.
Publicado: (2016)

Venetoclax for the treatment of translocation (11;14) AL amyloidosis
por: Sidiqi, M. Hasib, et al.
Publicado: (2020)

AL Amyloidosis
por: Desport, Estelle, et al.
Publicado: (2012)

Posterior longitudinal strain by speckle tracking echocardiography, marker of cardiac amyloidosis?
por: Ternacle, Julien, et al.
Publicado: (2015)

Feature tracking cardiac magnetic resonance in systemic light chain amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Advances in the treatment of hereditary transthyretin amyloidosis: A review
por: Gertz, Morie A., et al.
Publicado: (2019)

Importance of FISH genetics in light chain amyloidosis
por: Gertz, Morie A., et al.
Publicado: (2017)

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)

Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
por: Dispenzieri, Angela, et al.
Publicado: (2022)

Focal Amyloidosis of the Orbit Presenting as a Mass: MRI and CT Features
por: Yerli, Hasan, et al.
Publicado: (2011)

Clinical Features and Brain MRI Findings in Korean Patients with AGel Amyloidosis
por: Cheong, E-Nae, et al.
Publicado: (2021)

Layer-specific strain in patients with cardiac amyloidosis using tissue tracking MR
por: Li, Zheng, et al.
Publicado: (2023)

Contemporary Imaging Diagnosis of Cardiac Amyloidosis
por: Lee, Seung-Pyo, et al.
Publicado: (2019)

Two types of amyloidosis presenting in a single patient: a case series
por: Sidiqi, M. Hasib, et al.
Publicado: (2019)

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?
por: Rapezzi, Claudio, et al.
Publicado: (2021)

Biomarkers in AL Amyloidosis
por: Fotiou, Despina, et al.
Publicado: (2021)

Light Chain (AL) Amyloidosis: The Journey to Diagnosis
por: McCausland, Kristen L., et al.
Publicado: (2017)

Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome
por: Muchtar, Eli, et al.
Publicado: (2022)

Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
por: Morgan, Gareth J., et al.
Publicado: (2021)

Validating feature tracking MRI for the assessment of strain rate in patients with various hemodyanamic states
por: Holtzman, Dvorah, et al.
Publicado: (2012)

Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
por: Poshusta, Tanya L., et al.
Publicado: (2009)

Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design
por: Vaxman, I., et al.
Publicado: (2021)

Evaluating Prognosis in AL Amyloidosis: Can LV Strain Play a Role?
por: Falk, Rodney H., et al.
Publicado: (2020)

PB2151: CLINICAL FEATURES AND OUTCOMES OF DIFFUSE PULMONARY LIGHT CHAIN AMYLOIDOSIS: A RARE PRESENTATION OF SYSTEMIC AL AMYLOIDOSIS
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Comparison of right ventricular involvement in AL and transthyretin-type cardiac amyloidosis by cardiovascular magnetic resonance
por: Appelbaum, Evan, et al.
Publicado: (2009)

Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms
por: Gonzalez-Lopez, Esther, et al.
Publicado: (2022)

Unilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosis
por: Abdallah, Al-Ola, et al.
Publicado: (2012)

Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis
por: Lee Chuy, Katherine, et al.
Publicado: (2020)

Chronic diarrhea as the presenting feature of primary systemic AL amyloidosis: serendipity or delayed diagnosis?
por: Wang, Chen, et al.
Publicado: (2013)

The clinical features and outcomes of systemic AL amyloidosis: a cohort of 231 Chinese patients
por: Huang, Xianghua, et al.
Publicado: (2015)

Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics
por: Rognoni, Paola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tfkvrip7r4orcab9gjp70nm5gf